MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Tax Rate of 0.9% for Q1 2026, down 52.0% year-over-year from 1.88% in Q1 2025, and down 127.88% quarter-over-quarter from 0.4% in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Tax Rate history runs 6 years deep, the most recent figure standing at 0.9% for Q1 2026.
- In Q1 2026, Tax Rate fell 52.0% year-over-year to 0.9%; the TTM figure through Mar 2026 stood at 0.42% (down 17.0% YoY), while the FY2025 annual figure was 0.27%, down 3.0% from the prior year.
- Tax Rate for Q1 2026 stood at 0.9%, down from 0.4% in the prior quarter.
- The five-year high for Tax Rate was 0.05% in Q1 2022, with the low at 0.9% in Q1 2026.
- The 5-year median for Tax Rate is 0.17% (2025), against an average of 0.26%.
- The sharpest annual moves came in 2024 and 2026: Tax Rate jumped 47 bps in 2024, then sank 52 bps in 2026.
- MoonLake Immunotherapeutics' Tax Rate stood at 0.07% in 2022, then plunged by 737 bps to 0.56% in 2023, then soared by 84 bps to 0.09% in 2024, then tumbled by 347 bps to 0.4% in 2025, then tumbled by 128 bps to 0.9% in 2026.
- Business Quant data shows MLTX's Tax Rate at 0.9% in Q1 2026, 0.4% in Q4 2025, and 0.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | -0.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15% |
| Jun 30, 2026 | -0.15% |
| Jun 30, 2026 | -0.15% |
| Mar 31, 2026 | -0.90% |
| Mar 31, 2026 | -0.90% |
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -0.40% |
| Dec 31, 2025 | -0.40% |
| Dec 31, 2025 | -0.40% |
| Sep 30, 2025 | -0.16% |
| Sep 30, 2025 | -0.16% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -0.38% |
| Mar 31, 2025 | -0.38% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | -0.09% |
| Dec 31, 2024 | -0.09% |